Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MILESTONE SCIENTIFIC INC.MLSS · Entity 7313 | Director | October 22, 2024 | October 23, 2024 |
| Nexalin Technology, Inc.NXL · Entity 8197 | 10% owner | September 29, 2025 | September 30, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MILESTONE SCIENTIFIC INC.
Report date October 22, 2024 · Filed October 23, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, Par Value $0.001SEC Table I · non-derivative | Direct | 4,606,882 |
Reported balance
After 2024-10-22 transaction · row 1
1 source rowRow 1 · 2024-10-22 · Sale · Disposed 107,984 · Balance 4,606,882 |
Nexalin Technology, Inc.
Report date September 29, 2025 · Filed September 30, 2025
Jointly reported with Elson Marilyn
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,618,577 |
Reported balance
After 2025-09-29 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2025-09-29 · Grant · Acquired 83,333 · Balance 1,618,577 F1: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing |
Filing footnotes · ownership attribution and instrument terms
F1: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 29, 2025 Filed Sep 30, 2025 17:02 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantCommon Stock | 83,333 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-25-007778 · ownership.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · 10% owner Elson Marilyn · CIK 0001916491 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,618,577 F1 · balance_after: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 12:58 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | SaleCommon Stock Warrants · Derivative | 23,150 | $0.02 Strike: $4.15 | $402.81 |
DisclosureSEC source: 0001829126-25-007350 · ownership.xml · derivative · entry 1 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · 10% owner · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 112,850 Underlying: Common Stock · 23,150 shares Expires 2025-09-19 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 6 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 436,000 Underlying: Common Stock · 30,000 shares Expires 2030-07-17 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 5 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,000 Underlying: Common Stock · 30,000 shares Expires 2030-07-17 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 4 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 376,000 Underlying: Common Stock · 30,000 shares Expires 2030-07-17 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 3 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 346,000 Underlying: Common Stock · 30,000 shares Expires 2030-07-17 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 2 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,000 Underlying: Common Stock · 30,000 shares Expires 2030-07-17 Read SEC document |
| July 17, 2025 Filed Jul 21, 2025 12:35 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantStock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001829126-25-005220 · ownership.xml · derivative · entry 1 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 286,000 Underlying: Common Stock · 150,000 shares Expires 2030-07-17 Read SEC document |
| October 22, 2024 Filed Oct 23, 2024 20:55 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 107,984 | $0.93 | $100,425.12 |
DisclosureSEC source: 0001437749-24-031909 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,606,882 Read SEC document |
| September 30, 2024 Filed Oct 2, 2024 14:04 UTC Amendment | Nexalin Technology, Inc. NXL · Entity 8197 | GrantCommon Stock | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-006598 · ownership.xml · nonDerivative · entry 1 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,535,244 Read SEC document |
| September 23, 2024 Filed Sep 25, 2024 17:27 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | GrantCommon Stock | 700,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001829126-24-006465 · ownership.xml · nonDerivative · entry 1 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,535,244 Read SEC document |
| August 28, 2024 Filed Aug 30, 2024 21:04 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantCommon Stock, Par Value $0.001 | 112,356 | $0.89 | $99,996.84 |
DisclosureSEC source: 0001437749-24-028154 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,714,862 F1 · shares: Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2024, January 1, 2025, and April 1, 2025 Read SEC document |
| August 21, 2024 Filed Aug 21, 2024 21:03 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 141,913 | $0.95 | $134,817.35 |
DisclosureSEC source: 0001437749-24-027506 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,602,506 F1 · balance_after: 2,272,714 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| June 28, 2023 Filed Aug 10, 2023 22:30 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantCommon Stock, Par Value $0.001 | 112,360 | $0.89 | $100,000.40 |
DisclosureSEC source: 0001437749-23-023142 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,619,695 F1 · shares: Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock valued as of the close of business on the grant date of June 28, 2023, with one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2023, January 1, 2024, and April 1, 2024. F2 · balance_after: 2,019,266 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| September 28, 2022 Filed Sep 29, 2022 12:30 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon Stock | 9,500 | $1.12 | $10,640.00 |
DisclosureSEC source: 0001829126-22-017254 · ownership.xml · nonDerivative · entry 1 Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · shares owned jointly by reporting person and by spouse Disclosed balance after: 835,244 F1 · ownership.nature: Includes shares that Reporting Person owns with spouse Leonard Osser and for which Reporting Person has shared voting and dispositive power with spouse. Form 4 filed as joint ownership filing Read SEC document |
| September 28, 2022 Filed Oct 5, 2023 12:07 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon stock warrants · Derivative | 9,500 | $0.40 Strike: $4.15 | $3,800.00 |
DisclosureSEC source: 0001829126-23-006447 · ownership.xml · derivative · entry 1 Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,500 Underlying: Common Stock · 9,500 shares Expires 2025-09-19 Read SEC document |
| September 28, 2022 Filed Sep 25, 2024 17:26 UTC Amendment | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon stock warrants · Derivative | 36,000 | $0.40 Strike: $4.15 | $14,400.00 |
DisclosureSEC source: 0001829126-24-006464 · ownership.xml · derivative · entry 1 Elson Marilyn · CIK 0001916491 · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,000 Underlying: Common Stock · 36,000 shares Expires 2025-09-19 Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 14:29 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon stock warrants · Derivative | 100,000 | $0.40 Strike: $4.15 | $40,000.00 |
DisclosureSEC source: 0001829126-22-017010 · ownership.xml · derivative · entry 2 Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2025-09-19 Read SEC document |
| September 16, 2022 Filed Sep 20, 2022 14:29 UTC | Nexalin Technology, Inc. NXL · Entity 8197 | PurchaseCommon Stock | 36,000 | $4.15 | $149,400.00 |
DisclosureSEC source: 0001829126-22-017010 · ownership.xml · nonDerivative · entry 1 Elson Marilyn · CIK 0001916491 · Ms. Elson serves as CFO · 10% owner OSSER LEONARD · CIK 0001188354 · Spouse Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 825,744 Read SEC document |
| June 13, 2022 Filed Jun 15, 2022 15:48 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantCommon Stock, Par Value $0.001 | 30,488 | $0.82 | $25,000.16 |
DisclosureSEC source: 0001437749-22-015031 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,256,084 F1 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| June 13, 2022 Filed Oct 11, 2022 22:45 UTC Amendment | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | GrantCommon Stock, Par Value $0.001 | 121,951 | $0.82 | $99,999.82 |
DisclosureSEC source: 0001437749-22-023966 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,347,547 F1 · balance_after: Represents the annual fee paid to non-employee directors of $100,000, payable in restricted shares of the Company's common stock valued as of the close of business on the grant date of June 14, 2022, with one-fourth vesting upon the grant and the balance vesting in equal tranches over the next three quarters, October 1, 2022, January 1, 2023, and April 1, 2023. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 10:06 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 9,842 | $1.12 | $11,023.04 |
DisclosureSEC source: 0001437749-22-009275 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,225,596 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| April 12, 2022 Filed Apr 13, 2022 11:45 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,500 | $1.18 | $10,030.00 |
DisclosureSEC source: 0001437749-22-008795 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,235,438 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| April 11, 2022 Filed Apr 13, 2022 11:45 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,200 | $1.21 | $9,922.00 |
DisclosureSEC source: 0001437749-22-008795 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,243,938 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| April 04, 2022 Filed Apr 5, 2022 00:22 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 14,100 | $1.42 | $20,022.00 |
DisclosureSEC source: 0001437749-22-008249 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,252,138 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. Read SEC document |
| April 01, 2022 Filed Apr 5, 2022 00:22 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 6,000 | $1.51 | $9,060.00 |
DisclosureSEC source: 0001437749-22-008249 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,266,238 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. Read SEC document |
| March 28, 2022 Filed Mar 29, 2022 20:47 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,110 | $1.33 | $9,456.30 |
DisclosureSEC source: 0001437749-22-007561 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,272,238 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 00:02 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,000 | $1.26 | $10,080.00 |
DisclosureSEC source: 0001437749-22-006942 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,279,348 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 00:02 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,600 | $1.30 | $9,880.00 |
DisclosureSEC source: 0001437749-22-006942 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,287,348 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 22:08 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,500 | $1.18 | $10,030.00 |
DisclosureSEC source: 0001437749-22-006341 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,294,948 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 22:08 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,100 | $1.23 | $9,963.00 |
DisclosureSEC source: 0001437749-22-006341 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,303,448 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 08, 2022 Filed Mar 8, 2022 23:07 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,500 | $1.35 | $10,125.00 |
DisclosureSEC source: 0001437749-22-005579 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,311,548 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 07, 2022 Filed Mar 8, 2022 23:07 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 6,400 | $1.53 | $9,792.00 |
DisclosureSEC source: 0001437749-22-005579 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,319,048 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| March 01, 2022 Filed Mar 2, 2022 22:08 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,600 | $1.32 | $10,032.00 |
DisclosureSEC source: 0001437749-22-005041 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,325,448 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 28, 2022 Filed Mar 2, 2022 22:08 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,500 | $1.33 | $9,975.00 |
DisclosureSEC source: 0001437749-22-005041 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,333,048 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 23, 2022 Filed Feb 23, 2022 21:49 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,200 | $1.22 | $10,012.20 |
DisclosureSEC source: 0001437749-22-004196 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,340,548 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:49 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,700 | $1.29 | $9,894.50 |
DisclosureSEC source: 0001437749-22-004196 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,348,748 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 15, 2022 Filed Feb 15, 2022 22:22 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,100 | $1.24 | $10,044.00 |
DisclosureSEC source: 0001437749-22-003453 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,356,448 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 22:22 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,400 | $1.19 | $9,996.00 |
DisclosureSEC source: 0001437749-22-003453 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,364,548 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 08, 2022 Filed Feb 8, 2022 22:27 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,600 | $1.30 | $9,880.00 |
DisclosureSEC source: 0001437749-22-002764 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,372,948 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 07, 2022 Filed Feb 8, 2022 22:27 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 8,000 | $1.26 | $10,096.00 |
DisclosureSEC source: 0001437749-22-002764 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,380,548 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| February 01, 2022 Filed Feb 1, 2022 22:45 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock | 7,650 | $1.32 | $10,059.75 |
DisclosureSEC source: 0001437749-22-002129 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,388,548 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 31, 2022 Filed Feb 1, 2022 22:45 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock | 7,800 | $1.27 | $9,921.60 |
DisclosureSEC source: 0001437749-22-002129 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,396,198 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 25, 2022 Filed Jan 25, 2022 23:36 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 6,600 | $1.52 | $9,999.00 |
DisclosureSEC source: 0001437749-22-001610 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,403,998 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 24, 2022 Filed Jan 25, 2022 23:36 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 7,200 | $1.39 | $10,008.00 |
DisclosureSEC source: 0001437749-22-001610 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,410,598 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 19, 2022 Filed Jan 19, 2022 22:20 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 5,800 | $1.72 | $9,947.00 |
DisclosureSEC source: 0001437749-22-001235 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417,798 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 22:20 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 5,800 | $1.72 | $9,981.80 |
DisclosureSEC source: 0001437749-22-001235 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,423,598 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 11, 2022 Filed Jan 11, 2022 22:17 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 4,900 | $2.02 | $9,873.50 |
DisclosureSEC source: 0001437749-22-000737 · rdgdoc.xml · nonDerivative · entry 2 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,429,398 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 10, 2022 Filed Jan 11, 2022 22:17 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock, Par Value $0.001 | 5,000 | $2.02 | $10,095.00 |
DisclosureSEC source: 0001437749-22-000737 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,434,928 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 22:19 UTC | MILESTONE SCIENTIFIC INC. MLSS · Entity 7313 | SaleCommon Stock | 4,400 | $2.09 | $9,178.40 |
DisclosureSEC source: 0001437749-22-000556 · rdgdoc.xml · nonDerivative · entry 1 OSSER LEONARD · CIK 0001188354 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,439,928 F1 · kind: The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person, which became effective on December 13, 2021. F2 · balance_after: 1,602,600 of these shares are issuable to the reporting person at the termination of employment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.